Le centre hospitalier Jacques Cœur de Bourges, souvent appelé centre hospitalier Jacques Cœur, est un établissement public de santé situé à Bourges, dans le département du Cher, en région Centre-Val de Loire.

During the past decade, Centre Hospitalier Jacques Coeur conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centre Hospitalier Jacques Coeur" #1 sponsor was "Centre Hospitalier Departemental Vendee" with 2 trials, followed by "University Hospital, Tours" with 2 trials sponsored, "Abbott Medical Devices" with 1 trials sponsored, "Biotronik France" with 1 trials sponsored and "Centre Hospitalier Universitaire Dijon" with 1 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centre Hospitalier Jacques Coeur" #1 collaborator was "Biotronik SE & Co. KG" with 1 trials as a collaborator, "Institut Cancerologie de l'Ouest" with 1 trials as a collaborator, "Ministry of Health, France" with 1 trials as a collaborator and "The Lymphoma Study Association" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Centre Hospitalier Jacques Coeur" are "Critical Illness" (2 trials), "Abdominal Aortic Aneurysm" (1 trials), "Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis" (1 trials), "Atrial Fibrillation" (1 trials) and "Atrial Flutter" (1 trials). Many other conditions were trialed in "Centre Hospitalier Jacques Coeur" in a lesser frequency.

Most popular intervention types in "Centre Hospitalier Jacques Coeur" are "Drug" (4 trials), "Other" (3 trials), "Device" (2 trials), "Dietary Supplement" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "1 year follow-up to assess psychiatric morbidity" (1 trials), "6 months follow-up to assess the prevalence of PTSD symptoms" (1 trials), "Administration of the IPREA3 questionnaire" (1 trials), "BEACOPPesc" (1 trials) and "BEACOPPesc - ABVD - PET2" (1 trials). Other intervention names were less common.

The vast majority of trials in "Centre Hospitalier Jacques Coeur" are 12 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Centre Hospitalier Jacques Coeur". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Centre Hospitalier Jacques Coeur, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Centre Hospitalier Jacques Coeur, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".